{"created":"2021-03-01T06:12:53.426423+00:00","id":8848,"links":{},"metadata":{"_buckets":{"deposit":"b0cc1a1e-ffb9-4fd2-9fa5-bbee5c3135e9"},"_deposit":{"id":"8848","owners":[],"pid":{"revision_id":0,"type":"depid","value":"8848"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00008848","sets":["453:456","471:537:538:539"]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2014-09","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"9","bibliographicPageEnd":"471","bibliographicPageStart":"470","bibliographicVolumeNumber":"128","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"佐久間, 愛"}],"nameIdentifiers":[{"nameIdentifier":"61583","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"鈴木, 光幸"}],"nameIdentifiers":[{"nameIdentifier":"61584","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"石川, 達"}],"nameIdentifiers":[{"nameIdentifier":"61585","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"阿部, 聡司"}],"nameIdentifiers":[{"nameIdentifier":"61586","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"井上, 良介"}],"nameIdentifiers":[{"nameIdentifier":"61587","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"菅野, 智之"}],"nameIdentifiers":[{"nameIdentifier":"61588","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"渡邉, 雄介"}],"nameIdentifiers":[{"nameIdentifier":"61589","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"岩永, 明人"}],"nameIdentifiers":[{"nameIdentifier":"61590","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"関, 慶一"}],"nameIdentifiers":[{"nameIdentifier":"61591","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"本間, 照"}],"nameIdentifiers":[{"nameIdentifier":"61592","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"吉田, 俊明"}],"nameIdentifiers":[{"nameIdentifier":"61593","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-06"}],"displaytype":"detail","filename":"128(9)_470-5.pdf","filesize":[{"value":"203.2 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"128(9)_470-5.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/8848/files/128(9)_470-5.pdf"},"version_id":"5f1a544e-ba41-4796-9c67-1daae55a9d8f"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"5 C型慢性肝炎に対する第一世代direct actingviral agent (DAA) による副作用と入院加療率の検討（Ⅰ.一般演題, 第38回リバーカンファレンス）","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"5 C型慢性肝炎に対する第一世代direct actingviral agent (DAA) による副作用と入院加療率の検討（Ⅰ.一般演題, 第38回リバーカンファレンス）"},{"subitem_title":"5 C型慢性肝炎に対する第一世代direct actingviral agent (DAA) による副作用と入院加療率の検討（Ⅰ.一般演題, 第38回リバーカンファレンス）","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","539"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-09-16"},"publish_date":"2016-09-16","publish_status":"0","recid":"8848","relation_version_is_last":true,"title":["5 C型慢性肝炎に対する第一世代direct actingviral agent (DAA) による副作用と入院加療率の検討（Ⅰ.一般演題, 第38回リバーカンファレンス）"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:43:06.703290+00:00"}